抗血管内皮生长因子165(VEGF165)单克隆抗体

Anti-Vascular Endothelial Growth Factor 165 (VEGF165) Monoclonal Antibody

  • 抗血管内皮生长因子165(VEGF165)单克隆抗体 产品包装(模拟)
  • 抗血管内皮生长因子165(VEGF165)单克隆抗体 产品包装(模拟)
  • 抗血管内皮生长因子165(VEGF165)单克隆抗体 Human Hela cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10µg/ml mouse Anti-human VEGF165 Monoclonal Antibody (Catalog FAB696Hu02, red histogram) or Isotype control antibody (Catalog IS067-Mu02, green histogram), followed by 1µg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

用法

免疫印迹:0.2-2µg/mL;1:500-5000
免疫组织化学:5-20µg/mL;1:50-200
免疫细胞化学:5-20µg/mL;1:50-200
最佳稀释倍数最终由用户决定。

储存

经常使用则4°C保存。-20°C保存不超过一年。避免反复冻融。

赠品

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
APB696Hu61 血管内皮生长因子165(VEGF165)活性蛋白 Cell culture; Activity Assays.
APB696Hu01 血管内皮生长因子165(VEGF165)活性蛋白 Cell culture; Activity Assays.
RPB696Hu01 血管内皮生长因子165(VEGF165)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
EPB696Hu61 血管内皮生长因子165(VEGF165)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB696Hu01 血管内皮生长因子165(VEGF165)多克隆抗体 WB; IHC; ICC; IP.
MAB696Hu21 血管内皮生长因子165(VEGF165)单克隆抗体 WB; IHC
MAB696Hu22 血管内皮生长因子165(VEGF165)单克隆抗体 WB; IHC; ICC; IP.
MAB696Hu25 血管内皮生长因子165(VEGF165)单克隆抗体 WB; IHC; ICC; IP.
MAB696Hu24 血管内皮生长因子165(VEGF165)单克隆抗体 WB; IHC; ICC; IP.
MAB696Hu23 血管内皮生长因子165(VEGF165)单克隆抗体 WB; IHC; ICC; IP.
MAB696Hu26 血管内皮生长因子165(VEGF165)单克隆抗体 WB; IHC; ICC; IP.
MAB696Hu27 血管内皮生长因子165(VEGF165)单克隆抗体 WB; IHC; ICC; IP.
MAB696Hu29 血管内皮生长因子165(VEGF165)单克隆抗体 WB; IHC; ICC; IP.
FAB696Hu08 抗血管内皮生长因子165(VEGF165)单克隆抗体 Flow cytometry.
FAB696Hu06 抗血管内皮生长因子165(VEGF165)单克隆抗体 Flow cytometry.
FAB696Hu02 抗血管内皮生长因子165(VEGF165)单克隆抗体 Flow cytometry.
FAB696Hu04 抗血管内皮生长因子165(VEGF165)单克隆抗体 Flow cytometry.
SEB696Hu 血管内皮生长因子165(VEGF165)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB696Hu 血管内皮生长因子165(VEGF165)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.

参考文献

杂志 参考文献
Oncotarget Prohibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells. [pubmed:29100316]
Tissue Eng Regen Med Osteogenic and Angiogenic Potency of VEGF165-Transfected Canine Bone Marrow Mesenchymal Cells Combined with Coral Hydroxyapatite in Vitro [34302695]
留言咨询